APA (7th ed.) Citation

K, v. d. B., FN, v. E., JW, B., IE, v. H., JM, R., M, K., . . . GJ, C. (2025). Treatment Adherence to Adjuvant Chemotherapy According to the New Standard 3-month CAPOX Regimen in High-risk Stage II and Stage III Colon Cancer: A Population-based Evaluation in The Netherlands. Clinical colorectal cancer, 24(2), 300. https://doi.org/10.1016/j.clcc.2025.02.006

Chicago Style (17th ed.) Citation

K, van den Berg, van Erning FN, Burger JW, van Hellemond IE, Roodhart JM, Koopman M, Rutten HJ, and Creemers GJ. "Treatment Adherence to Adjuvant Chemotherapy According to the New Standard 3-month CAPOX Regimen in High-risk Stage II and Stage III Colon Cancer: A Population-based Evaluation in The Netherlands." Clinical Colorectal Cancer 24, no. 2 (2025): 300. https://doi.org/10.1016/j.clcc.2025.02.006.

MLA (9th ed.) Citation

K, van den Berg, et al. "Treatment Adherence to Adjuvant Chemotherapy According to the New Standard 3-month CAPOX Regimen in High-risk Stage II and Stage III Colon Cancer: A Population-based Evaluation in The Netherlands." Clinical Colorectal Cancer, vol. 24, no. 2, 2025, p. 300, https://doi.org/10.1016/j.clcc.2025.02.006.